Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA)
Condition: Arthritis, Rheumatoid Interventions: Biological: GSK3196165; Drug: csDMARD(s) Sponsors: GlaxoSmithKline; Iqvia Pty Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials